Cargando…
Characterization of renal biomarkers for use in clinical trials: biomarker evaluation in healthy volunteers
BACKGROUND: Several preclinical urinary biomarkers have been qualified and accepted by the health authorities (US Food and Drug Administration, European Medicines Agency, and Pharmaceuticals and Medical Devices Agency) for detecting drug-induced kidney injury during preclinical toxicologic testing....
Autores principales: | Brott, David A, Adler, Scott H, Arani, Ramin, Lovick, Susan C, Pinches, Mark, Furlong, Stephen T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3928457/ https://www.ncbi.nlm.nih.gov/pubmed/24611000 http://dx.doi.org/10.2147/DDDT.S54956 |
Ejemplares similares
-
Characterization of renal biomarkers for use in clinical trials: effect of preanalytical processing and qualification using samples from subjects with diabetes
por: Brott, David A, et al.
Publicado: (2015) -
Are Laboratory Parameter (Biomarker) Values Similar to the Healthy Volunteer Reference Range in Individuals with Diabetes
por: Brott, David A, et al.
Publicado: (2020) -
Are laboratory parameter (biomarker) values similar to the healthy volunteer reference range in all patient populations?
por: Brott, David A, et al.
Publicado: (2018) -
Benign elevations in serum aminotransferases and biomarkers of hepatotoxicity in healthy volunteers treated with cholestyramine
por: Singhal, Rohit, et al.
Publicado: (2014) -
Evaluation of the impact of renal impairment on the pharmacokinetics of glasdegib in otherwise healthy volunteers
por: Shaik, Naveed, et al.
Publicado: (2021)